Please login to the form below

Not currently logged in
Email:
Password:

Astronauts to trial healthcare wearables in space

Canadian Space Agency plans to test a 'smart shirt' in an upcoming mission
Carré Technologies Astroskin

A 'smart shirt' designed to remotely monitor the wearer's health via a series of sensors is set to be tested in space in an upcoming mission by the Canadian Space Agency (CSA).

It has signed a $2.4m deal with Carré Technologies that will see the wearable sensors developer's bio-monitoring system taken aboard the International Space Station (ISS) by Canadian astronaut David Saint-Jacques during a six-month mission in 2018-2019.

The wearable tech - called Astroskin - collects scientific data on activity levels, sleep quality and vital signs, including blood oxygen levels, blood pressure, heart rate and electrical activity, and breathing rate.

Pierre-Alexandre Fournier, co-founder and chief executive of Carré Technologies, said: “Deploying our wearable sensors and software to the ISS is significant as this represents the ultimate remote patient monitoring scenario.

“The findings tracking the health of astronauts will be used to make our healthcare system more accessible and support new home care and telemedicine services.”

The Astroskin developers already have an eye on the technology's future in cardiology and sleep treatment, and hope to use data collected from the ISS trial to help bring the product to market for health monitoring in hard-to-reach patients worldwide.

Canadian minister for transport Marc Garneau said: “Astroskin may have many applications on Earth, such as medical monitoring of those confined to their homes by illness, people living in remote areas with limited medical access, and those working in hazardous environments.

“It is another in a long list of space technologies brought down to Earth for all of us.”

Article by
Rebecca Clifford

24th October 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...